These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management]. Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439 [TBL] [Abstract][Full Text] [Related]
3. Understanding why probiotic therapies can be effective in treating IBD. Fedorak RN J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Geier MS; Butler RN; Howarth GS Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666 [TBL] [Abstract][Full Text] [Related]
5. Probiotics in inflammatory bowel disease--therapeutic rationale and role. Shanahan F Adv Drug Deliv Rev; 2004 Apr; 56(6):809-18. PubMed ID: 15063591 [TBL] [Abstract][Full Text] [Related]
6. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384 [TBL] [Abstract][Full Text] [Related]
7. Microecology as a target for therapeutic intervention in inflammatory bowel disease. Guarner F IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066 [TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of probiotics in inflammatory bowel diseases. Mach T J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485 [TBL] [Abstract][Full Text] [Related]
9. Probiotics in experimental and human inflammatory bowel disease: discussion points. Pagnini C; Cominelli F Dig Liver Dis; 2006 Dec; 38 Suppl 2():S270-3. PubMed ID: 17259089 [TBL] [Abstract][Full Text] [Related]
10. Effect of probiotics on intestinal barrier function. Mennigen R; Bruewer M Ann N Y Acad Sci; 2009 May; 1165():183-9. PubMed ID: 19538305 [TBL] [Abstract][Full Text] [Related]
12. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C; Whelan K; Lindsay JO Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082 [TBL] [Abstract][Full Text] [Related]
13. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? Seksik P; Dray X; Sokol H; Marteau P Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087 [TBL] [Abstract][Full Text] [Related]
15. Gut flora in health and disease: potential role of probiotics. Heselmans M; Reid G; Akkermans LM; Savelkoul H; Timmerman H; Rombouts FM Curr Issues Intest Microbiol; 2005 Mar; 6(1):1-7. PubMed ID: 15751747 [TBL] [Abstract][Full Text] [Related]
16. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease? Cary VA; Boullata J J Clin Nurs; 2010 Apr; 19(7-8):904-16. PubMed ID: 20492035 [TBL] [Abstract][Full Text] [Related]
17. Clinical utility of probiotics in inflammatory bowel disease. Cain AM; Karpa KD Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946 [TBL] [Abstract][Full Text] [Related]
19. Rationale for probiotic treatment strategies in inflammatory bowel disease. Schultz M; Lindström AL Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384 [TBL] [Abstract][Full Text] [Related]
20. Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease. Karimi O; Peña AS J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S136-41. PubMed ID: 18806706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]